NCT02410018View on ClinicalTrials.gov

Safety and Effectiveness of OCL 503 in the Treatment of Women With Leiomyomata

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Leiomyomata
Interventions
DEVICE

OCL 503 (uterine artery embolization)

Transcatheter embolization of the uterine artery(ies) using an embolic agent.

Trial Locations (1)

12208

Albany Medical Center, Albany

Sponsors
All Listed Sponsors
lead

IMBiotechnologies Ltd.

INDUSTRY